Status:

COMPLETED

A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions:

HIV Infections

Eligibility:

All Genders

2-21 years

Phase:

NA

Brief Summary

The purpose of this study is to find out if it is safe for HIV-positive children who are responding well to their anti-HIV treatment to stop taking medications that prevent AIDS-related infections (op...

Detailed Description

Due to the strong correlation between a significant decrease in CD4 count and the frequency and magnitude of OIs such as Pneumocystis carinii pneumonia (PCP), Mycobacterium avium complex (MAC), and se...

Eligibility Criteria

Inclusion Criteria

Children may be eligible for this study if they:

  • Are HIV-positive.
  • Have a CD4 percent greater than or equal to 25 percent if they are under 6 years of age, or have a CD4 percent greater than or equal to 20 percent on 2 occasions if they are between the ages of 6 and 21.
  • Have been receiving preventive treatment for PCP for at least 6 months and have not stopped treatment for more than 3 months before study entry.
  • Are willing to stop taking preventive treatment for PCP and MAC.
  • Have received the same continuous antiretroviral (anti-HIV) therapy for the 16 weeks before beginning the study. (Continuous therapy means missing no more than a total of 3 weeks during the 16 weeks.)
  • Are between the ages of 2 and 21 years (consent of parent or guardian is required if under 18).

Exclusion Criteria

Children will not be eligible for this study if they:

  • Have PCP.
  • Have any other active infection, such as tuberculosis or toxoplasmosis, or any other significant disease.
  • Are receiving chemotherapy for cancer or certain other medications.

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00001078

Last Update

March 2 2011

Active Locations (50)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 13 (50 locations)

1

Univ of Alabama at Birmingham - Pediatric

Birmingham, Alabama, United States, 35233

2

Phoenix Childrens Hosp

Phoenix, Arizona, United States, 85006

3

UCSD Med Ctr / Pediatrics / Clinical Sciences

La Jolla, California, United States, 920930672

4

Long Beach Memorial (Pediatric)

Long Beach, California, United States, 90801